...
首页> 外文期刊>American Journal of Physiology >Renoprotective effects of nitric oxide in angiotensin II-induced hypertension in the rat.
【24h】

Renoprotective effects of nitric oxide in angiotensin II-induced hypertension in the rat.

机译:一氧化氮对血管紧张素II诱发的大鼠高血压的肾脏保护作用。

获取原文
获取原文并翻译 | 示例

摘要

Experiments were performed in anesthetized male Sprague-Dawley rats to determine whether increased nitric oxide (NO) activity during the development of hypertension exerts a protective effect on renal cortical blood flow (CBF) and medullary blood flow (MBF). The effects of acute NO synthase inhibition on renal function and on CBF and MBF, measured by laser-Doppler flow probes, were evaluated in control and ANG II-infused hypertensive rats, prepared by the infusion of ANG II at a rate of 65 ng/min via osmotic minipumps implanted subcutaneously for 13 days. In normotensive rats (n = 8), intravenous infusion of N omega-nitro-L-arginine (NLA; 20 micrograms.100 g-1.min-1) decreased CBF by 21 +/- 4% and MBF by 49 +/- 8% and increased blood pressure from 118 +/- 1 to 140 +/- 2 mmHg. In ANG II-infused rats (n = 7), CBF and MBF decreased by 46 +/- 5% and 25 +/- 6%, respectively, during infusion of NLA. Arterial pressure increased from 160 +/- 5 to 197 +/- 7 mmHg, which was a greater absolute increase than in normotensive controls. Basal renal blood flow (RBF), estimated from p-aminohippurate clearance and hematocrit, was similar in both the control (6.0 +/- 0.5 ml.min-1.g-1) and hypertensive (6.0 +/- 0.6 ml.min-1.g-1) rats. However, NLA-induced reductions in RBF averaged 60 +/- 5% in the hypertensive rats, compared with 31 +/- 9% observed in control rats. GFR in control (0.97 +/- 0.03 ml.min-1.g-1) and hypertensive rats (0.78 +/- 0.12 ml.min-1.g-1) decreased to a similar extent during the first 30-min period of NLA infusion. GFR returned toward control levels in control rats; in contrast, GFR remained significantly decreased in the ANG II-infused rats (0.58 +/- 0.11 ml.min-1.g-1). Basal urinary sodium excretion (0.2 +/- 0.08 mueq.min-1.g-1), fractional excretion of sodium (0.3 +/- 0.13%), and urine flow (4.9 +/- 0.39 microliters.min-1.g-1) in hypertensive rats did not increase significantly after NLA treatment as occurred in normotensive controls. These data suggest that a compensatory increase in nitric oxide activity partially counteracts the vasoconstrictor influence of elevated ANG II levels to regulate renal hemodynamics and maintain cortical perfusion in the renal circulation.
机译:在麻醉的雄性Sprague-Dawley大鼠中进行了实验,以确定在高血压发展过程中增加的一氧化氮(NO)活性是否对肾皮质血流(CBF)和髓质血流(MBF)具有保护作用。在对照组和注射ANG II的高血压大鼠中评估急性NO合酶抑制对肾功能以及CBF和MBF的影响(通过激光多普勒血流探头测量),该大鼠通过以ng ng / ng的速度输注ANG II制备分钟通过渗透皮下植入的微型泵持续13天。在血压正常的大鼠(n = 8)中,静脉内输注NΩ-硝基-L-精氨酸(NLA; 20微克100 g-1.min-1)使CBF降低21 +/- 4%,MBF降低49 + / -8%,血压从118 +/- 1 mmHg增加到140 +/- 2 mmHg。在输注ANG II的大鼠(n = 7)中,在输注NLA期间,CBF和MBF分别降低了46 +/- 5%和25 +/- 6%。动脉压从160 +/- 5 mmHg增加到197 +/- 7 mmHg,这比血压正常对照的绝对升高更大。从对氨基马尿酸盐清除率和血细胞比容估算的基础肾血流量(RBF)在对照组(6.0 +/- 0.5 ml.min-1.g-1)和高血压(6.0 +/- 0.6 ml.min)中均相似-1.g-1)大鼠。然而,在高血压大鼠中,NLA诱导的RBF降低平均为60 +/- 5%,而在对照大鼠中则为31 +/- 9%。在最初的30分钟内,对照组(0.97 +/- 0.03 ml.min-1.g-1)和高血压大鼠(0.78 +/- 0.12 ml.min-1.g-1)的GFR下降程度相似NLA输注。对照大鼠的GFR恢复到对照水平;相比之下,在注入ANG II的大鼠中,GFR仍显着降低(0.58 +/- 0.11 ml.min-1.g-1)。基础尿钠排泄(0.2 +/- 0.08 mueq.min-1.g-1),钠的部分排泄(0.3 +/- 0.13%)和尿流(4.9 +/- 0.39微升.min-1.g -1)在NLA治疗后,高血压大鼠的血压没有像正常血压对照组那样明显增加。这些数据表明,一氧化氮活性的补偿性增加部分抵消了ANGII水平升高对血管收缩剂的影响,从而调节了肾脏的血流动力学并维持了肾循环中的皮质灌注。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号